Fluidigm Maxpar Metal-labeled Antibodies for Helios

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ1921890 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-99-1 as of July 2018. The North American Industry Classification System (NAICS) code for this procurement is 325414 , Biological Product Manufacturing, with a small business size standard of 1250 employees. The is a small business set aside. The acquisition is being competed as a brand name restriction. The National Institute of Allergy and Infectious Diseases (NIAID) has a brand name requirement for the following item. These supplies will be used in the NIAID, Laboratory of Systems Biology (LIS). Place of Performance: NIH, 4 Memorial Drive, Bethesda, MD 20814 FOB: Destination Brand name requirements: Manufactured by: Fluidigm https://www.fluidigm.com/ Description Catalog# Qty Anti-IkBa (Aminoterminal Antigen) (L35A5)-164Dy-50 Tests 3164004A 2 Anti-Human CD20 (2H7)-147Sm-100 Tests 3147001B 3 Anti-pCREB [S133] (87G3)-165Ho-50 Tests 3165009A 2 Anti-Human CD11c (Bu15)-159Tb-100 Tests 3159001B 1 Anti-Human CD45RA (HI100)- 169Tm-100 Tests 3169008B 1 Anti-Human IgD (IA6-2)-146Nd-100 Tests 3146005B 1 Anti-pERK1/2 [T202/Y204] (D13.14.4E)-171Yb -50 Tests 3171010A 3 Maxpar X8 Antibody Labeling Kit, 166Er-4 Rxn 201166A 1 Anti-Human CD38 (HIT2)-167Er-100 Tests 3167001B 1 Anti-pAkt [S473] (D9E)-152Sm-50 Tests 3152005A 6 Anti-pStat5 [Y694] (47)-150Nd-50 Tests 3150005A 2 Anti-Human CD4 (RPA-T4)-145Nd- 100 Tests 3145001B 2 Anti-Human CD27 (L128)-155Gd-100 Tests 3155001B 1 Anti-Human CD14 (M5E2)-160Gd- 100 Tests 3160001B 2 Anti-pStat3 [Y705] (4/P-STAT3)-158Gd -50 Tests 3158005A 3 Anti-pStat1 [Y701] (4a)-153Eu-50 Tests 3153005A 3 Anti-Human CD25 (2A3)-149Sm-100 Tests 3149010B 1 Maxpar X8 Antibody Labeling Kit, 141Pr-4 Rxn 201141A 1 Anti-Human CD8 (SK1)-168Er-100 Tests 3168002B 1 Anti-pPLCg2 [Y759] (K86-689.37)- 144Nd-50 Tests 3144015A 3 Anti-Human CD3 (UCHT1)-170Er- 100 Tests 3170001B 1 Anti-Human CD19 (HIB19)-142Nd- 100 Tests 3142001B 1 Anti-p38 [T180/Y182] (D3F9)- 156Gd-50 Tests 3156002A 2 Anti-pS6 [S235/S236] (N7-548)- 175Lu-50 Tests 3175009A 2 Anti-Human CD56 (NCAM16.2)-163Dy -100 Tests 3163007B 1 Anti-Human HLADR (L243)-174Yb- 100 Tests 3174001B 1 Maxpar X8 Antibody Labeling Kit, 154Sm-4 Rxn 201154A 1 Anti-Human CD123/IL-3R (6H6)-151Eu -100 Tests 3151001B 1 Maxpar X8 Antibody Labeling Kit, 176Yb-4 Rxn 201176A 1 Cell-IDTM 20-Plex Pd Barcoding Kit 201060 17 Cell-IDTM Intercalator-Ir-125 - M 201192A 2 CAS Solution-100 mL 201237 4 Maxpar Fix and Perm Buffer-100 mL 201067 2 Maxpar Cell Staining Buffer-500 mL 201068 6 EQ Four Element Calibration Beads- 100 mL 201078 2 Must be completely compatible with existing Helio system and established CyTOF assay. Additional requirements: Quotes must include the following: Delivery and shipping charges Place of manufacture Compatibility Statement if not the brand name requested. The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; capability to meet the technical requirements, delivery time, warranty, and price and the best value to the government. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (Oct 2014) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2017) Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Dec 2014) is updated in your SAM record) FAR 52.204-7 System for Award Management (July 2013) FAR 52.203-19 - Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements. The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (Jan 2017) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (July 2018) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.204-18 Commercial and Government Entity Code Maintenance (Nov 2014) FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (July 2013) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010) By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from https://www.acquisition.gov/browsefar & https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html or, upon request, either by telephone or fax. Submission shall be received not later than September 14, 2018 by 3:00 p.m. Eastern time Offers may be mailed, e-mailed to janna.weber@nih.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Janna Weber @ janna.weber@nih.gov